Simcere Pharma Grants 15.4 million RSUs Under Incentive Scheme; Shares Slip 4%

MT Newswires Live
2025/12/02

Simcere Pharmaceutical Group (HKG:2096) agreed to grant over 15.4 million restricted share units (RSUs) to 97 participants under a 2021 incentive scheme, a Monday Hong Kong bourse filing said.

Shares of the pharmaceutical firm were down nearly 4% in Tuesday afternoon trading.

The RSUs represent the same number of underlying shares.

The grantees include certain executive directors, members of the senior management, and 92 other employees.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10